AU507853B2 - N-(tetrazol-5-yl) prostaglandin carboxamides - Google Patents

N-(tetrazol-5-yl) prostaglandin carboxamides

Info

Publication number
AU507853B2
AU507853B2 AU43359/79A AU4335979A AU507853B2 AU 507853 B2 AU507853 B2 AU 507853B2 AU 43359/79 A AU43359/79 A AU 43359/79A AU 4335979 A AU4335979 A AU 4335979A AU 507853 B2 AU507853 B2 AU 507853B2
Authority
AU
Australia
Prior art keywords
tetrazol
carboxamides
prostaglandin
prostaglandin carboxamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU43359/79A
Other languages
English (en)
Other versions
AU4335979A (en
Inventor
Thomas Ken Schaaf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of AU4335979A publication Critical patent/AU4335979A/en
Application granted granted Critical
Publication of AU507853B2 publication Critical patent/AU507853B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU43359/79A 1978-01-16 1979-01-15 N-(tetrazol-5-yl) prostaglandin carboxamides Ceased AU507853B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US86956978A 1978-01-16 1978-01-16
US89373178A 1978-04-05 1978-04-05
US893731 1978-04-05
US869569 1992-04-16

Publications (2)

Publication Number Publication Date
AU4335979A AU4335979A (en) 1979-07-26
AU507853B2 true AU507853B2 (en) 1980-02-28

Family

ID=27128123

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43359/79A Ceased AU507853B2 (en) 1978-01-16 1979-01-15 N-(tetrazol-5-yl) prostaglandin carboxamides

Country Status (28)

Country Link
JP (1) JPS54100378A (no)
AR (1) AR222817A1 (no)
AT (1) AT367755B (no)
AU (1) AU507853B2 (no)
CA (1) CA1152502A (no)
CH (1) CH635833A5 (no)
DD (1) DD141155A5 (no)
DE (1) DE2901476C3 (no)
DK (1) DK523378A (no)
ES (1) ES482421A1 (no)
FI (1) FI790120A (no)
FR (1) FR2414503A1 (no)
GB (1) GB2012272B (no)
GR (1) GR72747B (no)
IE (1) IE48175B1 (no)
IL (1) IL56433A (no)
IN (1) IN150279B (no)
IT (1) IT1110992B (no)
LU (1) LU80789A1 (no)
NL (1) NL7900292A (no)
NO (1) NO790122L (no)
NZ (1) NZ189377A (no)
PH (3) PH15031A (no)
PL (1) PL117869B1 (no)
PT (1) PT69076A (no)
SE (1) SE427657B (no)
SU (1) SU831071A3 (no)
YU (1) YU4579A (no)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788209A (fr) * 1971-09-01 1973-02-28 Pfizer Derives tetrazoyliques des prostaglandines naturelles
DD118856A5 (no) * 1972-11-08 1976-03-20
IE43462B1 (en) * 1975-06-23 1981-03-11 Pfizer Substituted tetranorprostaglandins
DE2559093C3 (de) * 1975-12-30 1981-12-24 Pfizer Inc., 10017 New York, N.Y. 2-Desarboxy-2-[tetrazol-5-yl]-11-desoxy-ω-pentanorprostaglandine der E- oder F-Reihe und deren C↓15↓-Epimere
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives

Also Published As

Publication number Publication date
FI790120A (fi) 1979-07-17
PH15031A (en) 1982-05-13
NO790122L (no) 1979-07-17
NL7900292A (nl) 1979-07-18
IL56433A0 (en) 1979-03-12
PL117869B1 (en) 1981-08-31
GB2012272A (en) 1979-07-25
CA1152502A (en) 1983-08-23
IE790060L (en) 1979-07-16
LU80789A1 (fr) 1980-08-08
FR2414503B1 (no) 1981-12-24
ES482421A1 (es) 1980-04-01
YU4579A (en) 1983-01-21
SE427657B (sv) 1983-04-25
SU831071A3 (ru) 1981-05-15
DK523378A (da) 1979-07-17
PT69076A (en) 1979-02-01
IE48175B1 (en) 1984-10-17
DE2901476A1 (de) 1979-07-19
AT367755B (de) 1982-07-26
AR222817A1 (es) 1981-06-30
DE2901476B2 (de) 1981-06-04
CH635833A5 (fr) 1983-04-29
SE7900353L (sv) 1979-07-17
ATA27579A (de) 1981-12-15
IN150279B (no) 1982-09-04
AU4335979A (en) 1979-07-26
PH15653A (en) 1983-03-11
PL212183A1 (no) 1980-02-11
PH15643A (en) 1983-03-11
DE2901476C3 (de) 1982-04-22
JPS54100378A (en) 1979-08-08
GB2012272B (en) 1982-10-20
IT7919290A0 (it) 1979-01-15
FR2414503A1 (fr) 1979-08-10
DD141155A5 (de) 1980-04-16
IT1110992B (it) 1986-01-13
IL56433A (en) 1982-04-30
NZ189377A (en) 1981-05-15
GR72747B (no) 1983-12-02

Similar Documents

Publication Publication Date Title
AU530454B2 (en) Prostaglandin vasodilators
AU521611B2 (en) Complex salt photoinitiator
AU527837B2 (en) Substituted benzamide derivatives
AU514667B2 (en) Exhaust coupling
AU5156979A (en) Muffler
AU520740B2 (en) Drum
AU530907B2 (en) Prostanoid compounds
AU524112B2 (en) Electro-acoustic transducer
AU521741B2 (en) N-(diaminophosphinyl)arylcarboxamides
AU5082079A (en) Transducer support
AU521152B2 (en) Displacement transducers
AU525980B2 (en) Benzamide derivatives
AU503379B1 (en) Pressure transducer
AU527408B2 (en) N-(phenylcycloalkyl) acetamides
AU507853B2 (en) N-(tetrazol-5-yl) prostaglandin carboxamides
AU5131279A (en) Isocyanocarboxylic acid amides
AU518222B2 (en) Chloroacetanilides
ZA79149B (en) N-(tetrazol-5-yl)prostaglandin carboxamides
SU694779A1 (ru) Датчик давлени
AU522497B2 (en) Substituted 2-alkylideneamino benzamides
AU516742B2 (en) Indane-acetic acid aminoesters
AU4893079A (en) Electro-acoustic transducer
AU519908B2 (en) Polyfilar transducer
AU522953B2 (en) N-pyridothienopyrazol amide